HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy

Immunotherapy for prostate cancer: biology and therapeutic approaches

Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).

Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1

Treatment of high-grade glioma in children and adolescents

Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients

Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer

A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma